[1] Wang GS.Medical uses of Mylabris in ancient China and recent studies[J].J Ethnopharmacol,1989,26(2):147-162.
[2] Ho YP,To KK,Au-Yeung SC,et al.Potential new antitumor agents from an innovative combination of demethylcantharidin,a modified traditional Chinese medicine,with a platinum moiety[J].J Med Chem,2001,44(13):2065-2068.
[3] Massicot F,Dutertre-Catella H,Pham-Huy C,et al.In vitro assessment of renal toxicity and inflammatory events of two protein phosphatase inhibitors cantharidin and nor-cantharidin[J].Basic Clin Pharmacol Toxicol,2005,96(1):26-32.
[4] Wu LT,Chung JG,Chen JC,et al.Effect of norcantharidin on N-acetyltransferase activity in HepG2 cells[J].Am J Chin Med,2001,29(1):161-172.
[5] Chang C,Zhu YQ,Mei JJ,et al.Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells[J].J Exp Clin Cancer Res,2010,29:145.
[6] Li GQ,Zhang SJ,Lü JF,et al.Molecular mechanism of norcantharidin inducing apoptosis in liver cancer cells[J].Zhonghua Yi Xue Za Zhi,2010,90(30):2145-2148.
[7] Li XQ,Shao SH,Han XH,et al.Norcantharidin induces apoptosis in SMMC-7721 cells via the c-Jun-NH2-terminal kinase signaling pathways[J].Zhonghua Gan Zang Bing Za Zhi,2010,18(2):146-147.
[8] Li XQ,Shao SH,Fu GL,et al.Study on norcantharidin-induced apoptosis in SMMC-7721 cells through mitochondrial pathways[J].Chin J Integr Med,2010,16(5):448-452.
[9] Sun ZX,Ma QW,Zhao TD,et al.Apoptosis induced by norcantharidin in human tumor cells[J].World J Gastroenterol,2000,6(2):263-265.
[10] Fan YZ,Fu JY,Zhao ZM,et al.Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells[J].World J Gastroenterol,2005,11(16):2431-2437.
[11] Fan YZ,Fu JY,Zhao ZM,et al.The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism[J].Zhonghua Zhong Liu Za Zhi,2004,26(5):271-274.
[12] Fan YZ,Fu JY,Zhao ZM,et al.Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro[J].Hepatobiliary Pancreat Dis Int,2007,6(1):72-80.
[13] Fan YZ,Fu JY,Zhao ZM,et al.Influence of norcantharidin on proliferation,proliferation- related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells[J].Hepatobiliary Pancreat Dis Int,2004,3(4):603-607.
[14] Fan YZ,Zhao ZM,Fu JY,et al.Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo[J].Zhonghua Wai Ke Za Zhi,2006,44(9):618-622.
[15] Fan YZ,Zhao ZM,Fu JY,et al.Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo[J].Hepatobiliary Pancreat Dis Int,2010,9(4):414-422.
[16] Chen YJ,Kuo CD,Tsai YM,et al.Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells[J].Anticancer Drugs,2008,19(1):55-64.
[17] Yang PY,Chen MF,Tsai CH,et al.Involvement of caspase and MAPK activities in norcantharidin-induced colorectal cancer cell apoptosis[J].Toxicol In Vitro,2010,24(3):766-775.
[18] Peng F,Wei YQ,Tian L,et al.Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines:involvement of the CD95 receptor/ligand[J].J Cancer Res Clin Oncol,2002,128(4):223-230.
[19] Peng C,Liu X,Liu E,et al.Norcantharidin induces HT-29 colon cancer cell apoptosis through the alphavbeta 6-extracellular signal-related kinase signaling pathway[J].Cancer Sci,2009,100(12):2302-2308.
[20] Huang Y,Liu Q,Liu K,et al.Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action.Cytotechnology,2009,59(3):201-208.
[21] Yang PY,Chen MF,Kao YH,et al.Norcantharidin induces apoptosis of breast cancer cells:involvement of activities of mitogen activated protein kinases and signal transducers and activators of transcription.Toxicol In Vitro,2011,25(3):699-707.
[22] Yi SN,Wass J,Vincent P,et al.Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro[J].Leuk Res,1991,15(10):883-886.
[23] Li JL,Cai YC,Liu XH,et al.Norcantharidin inhibits DNA replication and induces apoptosis with the cleavage of initiation protein Cdc6 in HL-60 cells[J].Anticancer Drugs,2006,17(3):307-314.
[24] An WW,Wang MW,Tashiro SI,et al.Mitogen-activated protein kinase-dependent apoptosis in norcantharidin-treated A357-S2 cells is proceeded by the activation of protein kinase C[J].Chin Med J,2005,118(3):198-203.
[25] Kok SH,Hong CY,Kuo MY,et al.Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes[J].Oral Oncol,2003,39(1):19-26.
[26] Yang EB,Tang WY,Zhang K,et al.Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival[J].Cancer Lett,1997,117(1):93-98。
[27] Chen YN,Chen JC,Yin SC,et al.Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells[J].Int J Cancer,2002,100(2):158-165.
[28] Hong CY,Huang SC,Lin SK,et al.Norcantharidin-induced post-G (2)/M apoptosis is dependent on wild-type p53 gene[J].Biochem Biophys Res Commun,2000,276(1):278-285.
[29] Qiu Z,Zhu J,Harms JS,et al.Bovine herpesvirus VP22 induces apoptosis in neuroblastoma cells by upregulating the expression ratio of Bax to Bcl-2[J].Hum Gene Ther,2005,16(1):101-108.
[30] Zheng XL,Sun HX,Liu XL,et al.Astilbic acid induced COLO 205 cell apoptosis by regulating Bcl-2 and Bax expression and activating caspase-3[J].Acta Pharmacol Sin,2004,25(8):1090-1095.
[31] Bowen JM,Gibson RJ,Keefe DM,et al.Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans[J].Pathology,2005,37(1):56-62.
[32] Kok SH,Cheng SJ,Hong CY,et al.Northaridin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio[J].Cancer Lett,2005,217(1):43-52.
[33] Tomazic A,Pegan V,Ferlan-Marolt K,et al.Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma[J].Hepatogastroenterology,2004,51(60):1832-1837.
[34] Santini D,Tonini G,Vecchio FM,et al.Prognostic value of Bax,Bcl-2,p53,and TUNEL staining in patients with radically resected ampullary carcinoma[J].J Clin Pathol,2005,58(2):159-165.
[35] Morinaga S,Nakamura Y,Ishiwa N,et al.Expression of survivin mRNA associates with apoptosis,proliferation and histologically aggressive features in hepatocellular carcinoma[J].Oncol Rep,2004,12(6):1189-1194.
[36] Dai DJ,Lu CD,Lai RY,et al.Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells[J].World J Gastroenterol,2005,11(2):193-919.
[37] An WW,Gong XF,Wang MW,Tashiro S,Onodera S,Ikejima T.Northaridin induces apoptosis in HeLa cells through caspase,MAKPK,and Mitochondrial pathways[J].Acta Pharmacol Sin,2004,25(11):1502-1508.
[38] Li GQ,Zhang SJ,Lü JF,et al.Molecular mechanism of norcantharidin inducing apoptosis in liver cancer cells[J].Zhonghua Yi Xue Za Zhi,2010,90(30):2145-2148.
[39] Liu XH,Blazsek I,Comisso M,et al.Effects of norcantharidin,a protein phosphatase type-2A inhibitor,on the growth of normal and malignant haemopoietic cells[J].Eur J Cancer,1995,31A(6):953-963.
[40] McCluskey A,Ackland SP,Gardiner E,et al.The inhibition of protein phosphatases 1 and 2A:a new target for rational anti-cancer drug design?[J].Anticancer Drug Des,2001,16(6):291-303.
[41] Baba Y,Hirukawa N,Tanohira N,et al.Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin)[J].J Am Chem Soc,2003,125(32):9740-9749.
[42] Hart ME,Chamberlin AR,Walkom C,et al.Modified norcantharidins; synthesis,protein phosphatases 1 and 2A inhibition,and anticancer activity[J].Bioorg Med Chem Lett,2004,14(8):1969-1973.
[43] Kirsch DG,Doseff A,Chau BN,et al.Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c[J].J Biol Chem,1999,274(30):21155-21161.
[44] Enari M,Sakahira H,Yokoyama H,et al.A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD[J].Nature,1998,391(6662):43-50.
[45] Cheng EH,Kirsch DG,Clem RJ,et al.Conversion of Bcl-2 to a Bax-like death effector by caspases[J].Science,1997,278(5345):1966-1968.
[46] An WW,Wang MW,Tashiro S,et al.Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways[J].J Korean Med Sci,2004,19(4):560-566.
[47] Ramrez CJ,Haberbusch JM,Soprano DR,et al.Retinoic acid induced repression of AP-1 activity is mediated by protein phosphatase 2A in ovarian carcinoma cells[J].J Cell Biochem,2005,96(1):170-182.
[48] Davis RJ.MAPKs:new JNK expands the group[J].Trends Biochem Sci,1994,19(11):470-473.
[49] Garrington TP,Johnson GL.Organization and regulation of mitogenactivated protein kinase signaling pathways[J].Curr Opin Cell Biol,1999,11(2):211-218.
[50] Nelson JM,Fry DW.Akt,MAPK (Erk1/2),and p38 act in concert to promote apoptosis in response to ErbB receptor family inhibition[J].J Biol Chem,2001,276(18):14842-14847.
[51] Wu GS.The functional interactions between the p53 and MAPK signaling pathways[J].Cancer Biol Ther,2004,3(2):156-161.
[52] She QB,Huang C,Zhang Y,et al.Involvement of c-jun NH (2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis[J].Mol Carcinog,2002,33(4):244-250.
[53] Chen YN,Cheng CC,Chen JC,et al.Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells[J].Br J Pharmacol,2003,140(3):461-470.
[54] Chang C,Zhu YQ,Mei JJ,et al.Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells[J].J Exp Clin Cancer Res,2010,29:145.
[55] Li XQ,Shao SH,Fu GL,et al.Study on norcantharidin-induced apoptosis in SMMC-7721 cells through mitochondrial pathways.Chin J Integr Med,2010,16(5):448-452.
[56] Liao HF,Chen YJ,Chou CH,et al.Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production.Toxicol In Vitro,2011,25(1):206-212.[57] Chen YJ,Shieh CJ,Tsai TH,et al.Inhibitory effect of norcantharidin,a derivative compound from blister beetles,on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells[J].Anticancer Drugs 2005,16(3):293-299.
[58] Chen YJ,Chang WM,Liu YW,et al.A small-molecule metastasis inhibitor,norcantharidin,downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells[J].Chem Biol Interact,2009,181(3):440-446.
[59] Huang G,Chen L.Tumor vasculature and microenvironment normalization:a possible mechanism of antiangiogenesis therapy[J].Cancer Biother Radiopharm,2008,23(5):661-667.
[60] Rhee J,Hoff PM.Angiogenesis inhibitors in the treatment of cancer[J].Expert Opin Pharmacother,2005,6(10):1701-1711.
[61] Sato M,Arap W,Pasqualini R.Molecular targets on blood vessels for cancer therapies in clinical trials[J].Oncology (Williston Park),2007,21(11):1346-1352.
[62] Maniotis AJ,Folberg R,Hess A,et al.Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry[J].Am J Pathol,1999,155(3):739-752.
[63] Hendrix MJ,Seftor EA,Hess AR,et al.Molecular plasticity of human melanoma cells[J].Oncogene,2003,22(20):3070-3075.
[64] Vartanian AA,Stepanova EV,Gutorov SL,et al.Prognostic significance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma[J].Can J Urol,2009,16(4):4726-4732.
[65] Sun BC,Zhang SW,Zhao XL,et al.Vasculogenic mimicry is associated with shorter survival in hepatocellular carcinomas[J].Lab Invest,2006,86:1302.
[66] Fan YZ,Sun W,Zhang WZ,et al.Vasculogenic mimicry in human primary gallbladder carcinomas and clinical significance thereof[J].Zhonghua Yi Xue Za Zhi,2007,87(3):145-149.
[67] Sun W,Fan YZ,Zhang WZ,et al.A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro[J].J Exp Clin Cancer Res,2011,30:46
[68] Sun W,Shen ZY,Zhang H,Fan YZ,Zhang WZ,Zhang JT,Lu XS,Ye C.Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis[J].Oncol Rep,2012,27(6):1990-2002.
[69] Fan YZ.A new medical therapy model for the patients with cancer[J].J Tongji Univ (Med Sci),2009,30(1):1-6.
[70] Fan YZ,Sun W.Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy[J].World J Gastrointestinal Surg,2010,2(4):117-127.
[71] Fan YZ,Chen CQ,Zhao ZM,et al.Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms[J].Zhonghua Yi Xue Za Zhi,2006,86(10):693-699.
[72] Zhang JT,Fan YZ,Chen CQ,et al.Norcantharidin:A potential antiangiogenic agent for gallbladder cancers in vitro and in vivo [J].Int J Oncol,2012,4(5):1501-1514.
[73] Chen YJ,Tsai YM,Kuo CD,et al.Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect[J].Life Sci,2009,85(17-18):642-651.
